Sally C. Pipes
Commentary
Government Regulation Threatens Life-Saving Innovation
Drug Companies Are Delivering a “Golden Age of Medicine.” Let’s Protect It.
New vaccines for scourges like malaria and respiratory syncytial virus, or RSV. New cancer drugs that can cut death rates by half or even cause complete remission. The discovery of a biomarker that could identify people who would benefit from investigational drugs for Parkinson’s Disease. Breakthrough treatments that curb obesity ...
Commentary
Read about dangers of single-payer health care
Lawmakers Can’t Let Single-Payer Health Care Cross The Border—Or The Pond
Unfortunately, many progressives are determined to import something even more dangerous from Canada—single-payer health care. For decades, Canadians have shouldered burdensome taxes for the privilege of waiting weeks to receive subpar care. Things are just as bad in England’s government-run healthcare system. Read full article at Forbes
Commentary
Learn how price controls threaten access to drugs
Despite Democrats’ Celebratory Mood, It’s A Sad Day For American Patients.
President Joe Biden celebrated a milestone today—but American patients have no reason to cheer. The White House announced the first 10 prescription drugs that, starting in 2026, will be subject to price controls authorized by the Inflation Reduction Act . . . It’s laudable that lawmakers want to reduce out-of-pocket ...
Commentary
Learn About GOP Healthcare Reform Plans
Republican candidates have sensible ideas for Medicare reform
Though they didn’t mention them onstage, several GOP candidates have previously proposed ideas for Medicare reform. That’s a good thing. The program’s Part A hospital insurance trust fund is set to run out of money in 2031. Absent major changes, the program will only continue hurtling toward insolvency. The problem ...
Commentary
Read latest on government price controls
Medicaid Drug Price Transparency Rule Is More Sinister Than It Seems
The Biden administration claims to support price transparency in healthcare. The Centers for Medicare and Medicaid Services has formally warned hundreds of hospitals to comply with federal rules requiring them to post their prices publicly. And the agency just rolled out a new rule designed to “advance prescription drug transparency ...
Commentary
Read latest on single-payer healthcare
Left’s Rhetoric Unmoored from Reality: U.S. Likes Its Healthcare
Three in four rate their health plan as either good or very good. And satisfaction ratings barely differed across political, racial, or socioeconomic groups. America’s health insurance system isn’t perfect. But, as these numbers suggest, it works pretty well for most people — which is more than can be said for ...
Commentary
Read the latest about PBMs
It’s Time To End the PBM Shakedown
Who says bipartisanship is dead? In the House and Senate, members of both parties are advancing legislation to check the power of pharmacy benefit managers (PBMs), the self-dealing middlemen in the drug supply chain that inflate Americans’ spending on prescriptions by billions of dollars a year. By shining a light ...
Commentary
Another reason why single-payer would be bad for US
Britain Offers a Cautionary Tale for ‘Medicare for All’
King Charles III’s coronation wasn’t the only historic event Great Britain marked this year. The country’s revered National Health Service is celebrating this summer the 75th anniversary of its founding. It’s a birthday Americans should take note of. The NHS has been an inspiration to generations of American leftists, who ...
Commentary
Read latest about affirmative action
Ending medical-school affirmative action will be a plus for patients
The US Supreme Court effectively prohibited university admissions officers from giving preferential treatment to applicants based on their race this summer. Many medical-school leaders decried the high court’s ruling, claiming the ban will lead to less diversity within their student bodies, a less diverse crop of physicians and worse outcomes ...
Commentary
Cancer Patients Need Private Innovation, Not Gov’t Meddling
President Joe Biden just announced a new effort that he hopes will spur the development of better, more precise cancer surgery technologies. The program is part of his administration’s “Cancer Moonshot,” which aims to halve cancer death rates in the United States by 2047. Ironically, one of the biggest obstacles to achieving ...
Government Regulation Threatens Life-Saving Innovation
Drug Companies Are Delivering a “Golden Age of Medicine.” Let’s Protect It.
New vaccines for scourges like malaria and respiratory syncytial virus, or RSV. New cancer drugs that can cut death rates by half or even cause complete remission. The discovery of a biomarker that could identify people who would benefit from investigational drugs for Parkinson’s Disease. Breakthrough treatments that curb obesity ...
Read about dangers of single-payer health care
Lawmakers Can’t Let Single-Payer Health Care Cross The Border—Or The Pond
Unfortunately, many progressives are determined to import something even more dangerous from Canada—single-payer health care. For decades, Canadians have shouldered burdensome taxes for the privilege of waiting weeks to receive subpar care. Things are just as bad in England’s government-run healthcare system. Read full article at Forbes
Learn how price controls threaten access to drugs
Despite Democrats’ Celebratory Mood, It’s A Sad Day For American Patients.
President Joe Biden celebrated a milestone today—but American patients have no reason to cheer. The White House announced the first 10 prescription drugs that, starting in 2026, will be subject to price controls authorized by the Inflation Reduction Act . . . It’s laudable that lawmakers want to reduce out-of-pocket ...
Learn About GOP Healthcare Reform Plans
Republican candidates have sensible ideas for Medicare reform
Though they didn’t mention them onstage, several GOP candidates have previously proposed ideas for Medicare reform. That’s a good thing. The program’s Part A hospital insurance trust fund is set to run out of money in 2031. Absent major changes, the program will only continue hurtling toward insolvency. The problem ...
Read latest on government price controls
Medicaid Drug Price Transparency Rule Is More Sinister Than It Seems
The Biden administration claims to support price transparency in healthcare. The Centers for Medicare and Medicaid Services has formally warned hundreds of hospitals to comply with federal rules requiring them to post their prices publicly. And the agency just rolled out a new rule designed to “advance prescription drug transparency ...
Read latest on single-payer healthcare
Left’s Rhetoric Unmoored from Reality: U.S. Likes Its Healthcare
Three in four rate their health plan as either good or very good. And satisfaction ratings barely differed across political, racial, or socioeconomic groups. America’s health insurance system isn’t perfect. But, as these numbers suggest, it works pretty well for most people — which is more than can be said for ...
Read the latest about PBMs
It’s Time To End the PBM Shakedown
Who says bipartisanship is dead? In the House and Senate, members of both parties are advancing legislation to check the power of pharmacy benefit managers (PBMs), the self-dealing middlemen in the drug supply chain that inflate Americans’ spending on prescriptions by billions of dollars a year. By shining a light ...
Another reason why single-payer would be bad for US
Britain Offers a Cautionary Tale for ‘Medicare for All’
King Charles III’s coronation wasn’t the only historic event Great Britain marked this year. The country’s revered National Health Service is celebrating this summer the 75th anniversary of its founding. It’s a birthday Americans should take note of. The NHS has been an inspiration to generations of American leftists, who ...
Read latest about affirmative action
Ending medical-school affirmative action will be a plus for patients
The US Supreme Court effectively prohibited university admissions officers from giving preferential treatment to applicants based on their race this summer. Many medical-school leaders decried the high court’s ruling, claiming the ban will lead to less diversity within their student bodies, a less diverse crop of physicians and worse outcomes ...
Cancer Patients Need Private Innovation, Not Gov’t Meddling
President Joe Biden just announced a new effort that he hopes will spur the development of better, more precise cancer surgery technologies. The program is part of his administration’s “Cancer Moonshot,” which aims to halve cancer death rates in the United States by 2047. Ironically, one of the biggest obstacles to achieving ...
